Sign Up!
Login
8 pharmaceutical cos > doubled their lobbying spending in the 1st 3 mos of 2017, when Affordable Care Act was on the block & high drug prices were clearly in the crosshairs of Congress & President Donald Trump. How do we combat these lobbies?
Comments: Add Comment